Associated Papers
Cancer-associated point mutations within the extracellular domain of PTPRD affect protein stability and HSPG interaction.
Matsui Y et al.
Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2024
EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.
Li Z et al.
Bmc Pulmonary Medicine, 2022
36123678 (PubMed )
Supplement: 12890_2022_2161_MOESM2_ESM.xlsx › OAK_POPLAR_btmb_variants
Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC.
Sun Y et al.
Bmc Medicine, 2021
34615542 (PubMed )
Supplement: 12916_2021_2075_MOESM1_ESM.pdf
Select a paper to view details